Summary:
A study to compare the effect of an investigational medication to insulin degludec on blood sugar levels in adult participants with type 2 diabetes.
Qualified Participants Must:
• Be 18 years old or older
•
Have been diagnosed with type 2 diabetes mellitus
•
Have an HbA1c value of 7.0% to 10.5%, inclusive
•
Be on stable treatment with unchanged dose of metformin alone or metformin plus an SGLT-2 inhibitor for at least 3 months
Qualified Participants May Receive:
- Reimbursement for time and travel
- Study-related care and study medicine at no cost (no health insurance required)